Navigation Links
Hemostemix Hosts Cell Therapy Industry Seminar
Date:10/30/2013

Toronto, Canada & Kyriat Weizmann, Israel (PRWEB) October 31, 2013

Hemostemix Ltd. and BioForum have announced a jointly-sponsored symposium entitled “Cell Therapy – an evolving industry” to be held November 4 at the Dan Hotel in Tel Aviv, Israel.

The event will feature invited speakers including Dr. Elmar Burchardt, Pfizer’s Vice President of Regenerative Medicine and cell therapy executives from Canada, United States, India, and Israel. The seminar will brief attendees on global industry trends, discuss optimal cell therapy product development, review the impact of CROs on clinical trial outcomes, present key elements of cellular product analytics, outline cell therapy business models, and engage in an open dialogue about the potential keys to cell therapy being a pillar of future healthcare.

“We are pleased to play a role in hosting an event which highlights the global cell therapy industry,” stated Hemostemix President and founder, Dr. Valentin Fulga. “With this seminar, and others planned, we want to facilitate an information-exchange and dialogue between investors, clinicians, and scientists that will promote a greater understanding of how cell therapies will shape the future of medicine.”

“Bioforum is excited to provide what it believes will be an important and useful seminar in this exciting new field of science and medicine,” stated Yehudith Wexler, Chairperson of Bioforum.
For more information about the seminar, click here.

This seminar is part of a series of presentations intended to introduce the company and its platform technology to a wide audience in the context of the cell therapy industry’s progress and maturation. This includes a recent keynote presentation (“Synergetic Cell Population – a powerful tool for autologous therapies”) delivered October 23rd in Orlando, FL and an upcoming presentation (“A peripheral blood-derived cellular population can be differentiated into neural like progenitor cells”) at the TERMIS-AM 2013 Conference to be held November 10-13in Atlanta, Georgia.

About Hemostemix Ltd

Hemostemix Ltd is a Canadian-Israeli company developing and commercializing innovative blood-derived cell therapies for medical conditions not adequately addressed by current treatments with an operating research, development and manufacturing facility in Kiryat Weizmann Science Park, Ness Ziona. For more information see http://www.hemostemix.com.

About Bioforum

Established in 1998, Bioforum provides a wide range of services in the areas of Education and Training, Clinical Data, Regulatory Submissions and Clinical Supply (inPACK). Bioforum's strategic lines of business combine professional services, process optimization, technology and education. Bioforum maximizes their costumers’ benefits by providing cost effective outsourcing and consultation services for the pharmaceutical, medical and medical device industries. For more information about Bioforum, see http://www.bioforum.co.il.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11280279.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Hemostemix Announces Formation of Scientific Advisory Board
2. Hemostemix Announces US Patent Allowance
3. The Hemostemix Group of Companies Provides Corporate Strategy Update
4. Funding Tomorrow's Biomedical Research: California Healthcare Institute Hosts Pipeline for Life, July 15
5. DTx Hosts Webinar on New Intel® Haswell Platform
6. Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013
7. Industry Leader Linguamatics Hosts Record-breaking Spring Users Conference in Cambridge, UK
8. Cambridge College School of Management Program Hosts a Panel Discussion On Trends and Opportunities In Health Information Technology
9. San Diego State University Hosts Open House for Life Science Immersion Biotechnology Program
10. Ultra Light Startups Hosts Future Energy Investor Feedback Forum at MIT
11. Bayer CropScience Hosts Third Sustainability in Agriculture: A Bayer Executive Course
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... Patient Monitoring and Diagnostic ... connectivity to reduce the amount of wiring in a healthcare facility and allow ... devices including infusion pumps, heart and hypertension monitoring, glucose monitoring, and other wearable ...
(Date:5/23/2017)... ... May 23, 2017 , ... Genedata, a leading ... marking the occasion with a strong presence at Bio-IT World Conference & Expo ... extends an invitation to all attendees to view posters on the entire ...
(Date:5/23/2017)... ... May 23, 2017 , ... Kathy Goin is joining ... She brings years of expertise in establishing and leading clinical operations at Sponsors ... licensed occupational therapist, through a variety of leadership roles in Clinical Operations, to ...
(Date:5/22/2017)... Baltimore, Maryland (PRWEB) , ... May 22, 2017 ... ... Ted Olsen, joined with other leaders of the Maryland Biohealth community in developing ... a globally recognized Top 3 U.S. BioHealth Innovation Hub by 2023. ...
Breaking Biology Technology:
(Date:5/16/2017)... -- Veratad Technologies, LLC ( www.veratad.com ), an innovative and ... solutions, announced today they will participate as a sponsor ... May 17, 2017, in Washington D.C.,s ... Identity impacts the lives of billions of ... digital world, defining identity is critical to nearly every ...
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at http://www.sec.gov . 2016 ...
Breaking Biology News(10 mins):